Distance to diagnosing provider as a measure of access for patients with melanoma

Archives of Dermatology

Volumn 143, Issue 8, 2007, Pages 991-998

  Stitzenberg, Karyn B ^a   Thomas, Nancy E ^a,b   Dalton, Kathleen ^a,b   Brier, Sarah E ^a   Ollila, David W ^a,b   Berwick, Marianne ^c   Mattingly, Dianne ^b   Millikan, Robert C ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTITUDE TO HEALTH; BIVARIATE ANALYSIS; CANCER DIAGNOSIS; CONFIDENCE INTERVAL; DEMOGRAPHY; DERMATOLOGY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PATIENT CARE; POVERTY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RURAL AREA; SCHOOL CHILD; SEX DIAGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DATABASES, FACTUAL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NORTH CAROLINA; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 34548064992     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.8.991     Document Type: Article

References (35)

1. Chang AE, Karnell LH, Menck HR; American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer. 1998;83(8):1664-1678.
2. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst. 1996;88(1):17-23.
3. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622-3634.
4. Bono A, Bartoli C, Cascinelli N, et al. Melanoma detection: a prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology. 2002;205(4):362-366.
5. Wolf IH, Smolle J, Soyer HP, Kerl H. Sensitivity in the clinical diagnosis of malignant melanoma. Melanoma Res. 1998;8(5):425-429.
6. Hallock GG, Lutz DA. Prospective study of the accuracy of the surgeon's diagnosis in 2000 excised skin tumors. Plast Reconstr Surg. 1998;101(5):1255-1261.
7. Curley RK, Cook MG, Fallowfield ME, Marsden RA. Accuracy in clinically evaluating pigmented lesions. BMJ. 1989;299(6690):16-18.
8. Institute of Medicine. Access to Health Care in America. Washington, DC: National Academy Press; 1993.
9. Sherwood PR, Stommel M, Murman DL, Given CW, Given BA. Primary malignant brain tumor incidence and Medicaid enrollment. Neurology. 2004;62(10):1788-1793.
10. Schwartz KL, Crossley-May H, Vigneau FD, Brown K, Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control. 2003;14(8):761-766.
11. O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. Cancer. 2003;97(5):1303-1311.
12. Kaffashian F, Godward S, Davies T, Solomon L, McCann J, Duffy SW. Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. Br J Cancer. 2003;89(9):1693-1696.
13. Iredale R, Jones L, Gray J, Deaville J. "The edge effect": an exploratory study of some factors affecting referrals to cancer genetic services in rural Wales. Health Place. 2005;11(3):197-204.
14. Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J. Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer. 2002;87(6):585-590.
15. Lamont EB, Hayreh D, Pickett KE, et al. Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst. 2003;95(18):1370-1375.
16. Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract. 1997;5(6):361-366.
17. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92(3):269-271.
18. MacKie RM, Hole DJ. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. BMJ. 1996;312(7039):1125-1128.
19. Geller AC, Miller DR, Lew RA, Clapp RW, Wenneker MB, Koh HK. Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts. Am J Public Health. 1996;86(4):538-544.
20. Roetzheim RG, Pal N, Van Durme DJ, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol. 2000;43(2, pt 1):211-218.
21. Van Durme DJ, Ferrante JM, Pal N, Wathington D, Roetzheim RG, Gonzalez EC. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med. 2000;9(7):606-611.
22. Van Durme DJ, Ullman R, Campbell RJ, Roetzheim R. Effects of physician supply on melanoma incidence and mortality in Florida. South Med J. 2003;96(7):656-660.
23. Girgis A, Bonevski B, Perkins J, Sanson-Fisher R. Self-reported cervical screening practices and beliefs of women from urban, rural and remote regions. J Obstet Gynaecol. 1999;19(2):172-179.
24. Lenhard RE Jr, Enterline JP, Crowley J, Ho GY. The effects of distance from primary treatment centers on survival among patients with multiple myeloma. J Clin Oncol. 1987;5(10):1640-1645.
25. Kreher NE, Hickner JM, Ruffin MT IV, Lin CS; Upper Peninsula Research Network. Effect of distance and travel time on rural women's compliance with screening mammography: an UPRNet study. J Fam Pract. 1995;40(2):143-147.
26. Begg CB, Orlow I, Hummer AJ, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst. 2005;97(20):1507-1515.
27. Begg CB, Hummer A, Mujumdar U, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004;15(9):957-965.
28. Fortney J, Rost K, Warren J. Comparing alternative methods of measuring geographic access to health services. Health Serv Outcomes Res Methodol. 2000;1(2):173-184.
29. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R; Public Health Disparities Geocoding Project. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? Am J Epidemiol. 2002;156(5):471-482.
30. Chao C, Martin RC II, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol. 2004;11(3):259-264.
31. Cohen HJ, Cox E, Manton K, Woodbury M. Malignant melanoma in the elderly. J Clin Oncol. 1987;5(1):100-106.
32. Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol. 1994;1(6):487-494.
33. Rushton G, Peleg I, Banerjee A, Smith G, West M. Analyzing geographic patterns of disease incidence: rates of late-stage colorectal cancer in Iowa. J Med Syst. 2004;28(3):223-236.
34. O'Donnell BF, Marsden JR, O'Donnell CA, Sanders DS, Billingham C. Does palpability of primary cutaneous melanoma predict dermal invasion? J Am Acad Dermatol. 1996;34(4):632-637.
35. Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Delfino M. Clinical and dermatoscopic criteria for the preoperative evaluation of cutaneous melanoma thickness. J Am Acad Dermatol. 1999;40(1):61-68.